Congruence is a computationally-driven biotechnology company building a unique pipeline of transformative small molecule correctors rationally designed to rescue aberrant protein function. Our proprietary scalable platform, Revenir™, captures the biophysical features of proteins across their conformational ensembles, in order to identify novel allosteric and cryptic pockets which are virtually screened to generate novel chemical matter.
| Website | https://congruencetx.com |
| Employees | 42 (35 on RocketReach) |
| Founded | 2021 |
| Address | 7171 Rue Frederick-Banting, 117, Montreal, Quebec H4S 1Z9, CA |
| Industry | Biotechnology Research |
| Keywords | Biotechnology, Small Molecule Drugs, Drug Discovery, Computational Biology, Therapeutics, Pharmaceutical Research, Precision Medicine, Rare Diseases, Biopharma, Drug Development, Life Sciences, Pharmaceutical, Biotechnology Platform, Molecular Design, Protein Engineering, Genetic Disorders, Innovative Therapies, Transformative Medicine |
| Competitors | Pfizer, Amgen, AstraZeneca, Biogen, AbCellera, Moderna Therapeutics, WuXi AppTec, Zymeworks Inc., Altoida, Inc., Lilly India +39 more (view full list) |
Looking for a particular Congruence Therapeutics employee's phone or email?
Congruence Therapeutics Questions
Charles Grubsztajn is the COO of Congruence Therapeutics.
35 people are employed at Congruence Therapeutics.
Congruence Therapeutics is based in Montreal, Quebec.
Top Congruence Therapeutics Employees
-
21
-
2
-
Sharath Hegde
Chief Scientific Officer at Congruence Therapeutics
South San Francisco, CA, US32 -
Lee Fader
Vice President, Chemistry at Congruence Therapeutics
Montreal, QC, CA25 -
45+
-
14
-
21
-
Jeremy Dupaul-Chicoine
Associate Director at Congruence Therapeutics
Montreal, QC, CA21
Related Companies
